Neil J. Shah, Manojkumar Bupathi, Rana R. McKay, Benjamin Garmezy, Hamid Emamekhoo, Edward Paul Gelmann, Joel Picus, Brendan D. Curti, Robert A. Figlin, Hans J. Hammers, Elaine T. Lam, Pedro C. Barata, Thomas E. Hutson, Moshe C. Ornstein, Brian H. Rank, Mohamad Adham Salkeni, Song Zhao, Michael Jon Chisamore, Nandita Bose, Robert J. Motzer. "A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with locally advanced (inoperable) or metastatic renal cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4534